Major Research Areas

Researchers in the College of Graduate Studies focus their efforts where it truly matters—on the diseases and illnesses that affect many people. Much of our research activity is grouped into four areas of concentration: cancer; infectious diseases; disorders of the nervous system; and diabetes, metabolic disorders and cardiovascular diseases.

Dimitra Bourboulia, PhD

Dimitra Bourboulia, PhD
Appointed 08/19/13
3234 Weiskotten Hall
766 Irving Ave.
Syracuse, NY 13210

315 464-8712

Current Appointments

Hospital Campus

Research Programs and Affiliations

  • Biomedical Sciences Program
  • Urology

Education & Fellowships

  • Fellowship: National Cancer Institute, NIH, Bethesda, MD, 2013
  • Fellowship: University of London, UK, 2007
  • PhD: University of London, UK, 2004

Previous Appointments

  • National Institutes of Health, 2007–2013
  • University of London, UK, 1999–2007

Research Interests

  • * Cancer Biology and Cell Signaling

    * Molecular mechanisms of cancer progression

    * Prostate cancer development and progression

Languages Spoken (Other Than English)

  • Greek


Link to PubMed External Icon (Opens new window. Close the PubMed window to return to this page.)


Tumor cell growth and migration begin with the secretion of proteolytic enzymes that degrade the extracellular matrix (ECM) followed by an invasion of the tumor vasculature leading to initiation of metastasis. Matrix Metalloproteases (MMPs) and their endogenous inhibitors (TIMPs) are key components of extracellular proteolysis and regulators of the tumor microenvironment (TME). Identification of ways to inhibit early matrix proteolysis would enhance our ability to target early tumor development and prevent metastatic potential. Studies have suggested that MMP/TIMP balance is shifted towards MMP activation during cancer progression.

Our laboratory investigates how MMPs and TIMPs are regulated during oncogenesis, leading to decisive biological events including proteolysis and cancer progression. Current research is concentrated in two areas: (1) Post-translational regulation of the MMP endogenous inhibitors, TIMPs and in particular TIMP-2, and how this regulation contributes to TIMP-2 anti-tumoral and anti-angiogenic properties. (2) Identification of novel therapeutic targets for prostate cancer (PCa), via elucidation of how cell secreted protein networks, including MMPs, TIMPs, matrix glycoproteins, promote tumor progression.


Faculty Profile Shortcut: